Optinose Announces Reporting Date for First Quarter 2022 Financial Results

Rhea-AI Summary

Optinose (NASDAQ:OPTN) will report its first-quarter 2022 financial results and corporate updates on May 12, 2022, before market open. A conference call hosted by the leadership team is scheduled for the same day at 8:00 a.m. Eastern Time. Participants can join the call by dialing the provided numbers or accessing a simultaneous webcast on the company’s website. A replay of the call will be available until May 19, 2022. Optinose specializes in pharmaceuticals for ear, nose, and throat (ENT) and allergy care, focusing on patient needs.

Conference Call and Webcast to be held May 12, 2022, at 8:00 a.m. Eastern Time

YARDLEY, Pa., May 05, 2022 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the first quarter 2022 and corporate updates, before market open on Thursday, May 12, 2022.

Company to Host Conference Call
Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m. Eastern Time on Thursday, May 12, 2022.

To participate on the conference call, please dial (866) 916-4761 from the U.S. or +1 (409) 216-6496 from outside the U.S. In addition, following the completion of the call, a telephone replay will be accessible until Thursday, May 19, 2022, by dialing (855) 859-2056 from the U.S. or +1 (404) 537-3406 from outside the U.S. and entering conference ID #4999838. A simultaneous webcast of the call and presentation can be accessed by visiting the Investors section of Optinose’s website at www.optinose.com. In addition, a replay of the webcast will be available on the Company website for 60 days following the event.

About Optinose
Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531

FAQ

When will Optinose report its Q1 2022 financial results?

Optinose will report its first-quarter 2022 financial results on May 12, 2022, before market open.

What time is the Optinose conference call scheduled?

The conference call is scheduled for May 12, 2022, at 8:00 a.m. Eastern Time.

How can I listen to the Optinose conference call?

You can listen to the Optinose conference call by dialing the provided numbers or accessing the webcast available on their website.

Will there be a replay of the Optinose conference call?

Yes, a replay of the call will be available until May 19, 2022.

What does Optinose specialize in?

Optinose specializes in pharmaceuticals for ear, nose, and throat (ENT) and allergy care.